Related Experiment Video

Updated: May 23, 2026

Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells
06:09

Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells

Published on: June 7, 2019

Pten regulates Aurora-A and cooperates with Fbxw7 in modulating radiation-induced tumor development

Yong-Won Kwon1, Il-Jin Kim, Di Wu

  • 1Life Sciences Division, Lawrence Berkeley National Laboratory, University of California, Berkeley, CA 94720, USA.

Molecular Cancer Research : MCR
|April 20, 2012
PubMed

Insights

The F-box protein FBXW7 targets Aurora-A kinase for degradation, a process regulated by GSK3β. Loss of Pten stabilizes Aurora-A by inhibiting this pathway, suggesting cooperation between Fbxw7 and Pten in cancer suppression.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Aurora-A kinase is frequently amplified and overexpressed in human cancers.
  • Targeting Aurora-A is a key strategy for cancer therapy.
  • Understanding Aurora-A regulation is crucial for developing effective treatments.

Purpose of the Study:

  • To elucidate the posttranslational regulatory mechanisms controlling Aurora-A protein levels.
  • To investigate the role of FBXW7 and GSK3β in Aurora-A degradation.
  • To explore the interplay between Pten, Fbxw7, and Aurora-A in tumorigenesis.

Main Methods:

  • Site-directed mutagenesis and truncated protein analysis to identify binding sites.
  • Biochemical assays to study ubiquitination and degradation pathways.
  • In vivo studies using genetically modified mouse models (Fbxw7(+/-)Pten(+/-)).

Main Results:

  • FBXW7 targets Aurora-A for ubiquitination and degradation, regulated by GSK3β.
  • Distinct FBXW7 and GSK3β binding sites on Aurora-A were identified.
  • Loss of Pten stabilizes Aurora-A by inhibiting FBXW7-dependent degradation via the AKT/GSK3β pathway.
  • Combined loss of Fbxw7 and Pten significantly shortens radiation-induced tumor latency in mice.

Conclusions:

  • A novel regulatory network involving Pten and Fbxw7 converges on Aurora-A level regulation.
  • FBXW7-mediated degradation of Aurora-A is a critical tumor suppressor mechanism.
  • The Pten/AKT/GSK3β pathway modulates Aurora-A stability, impacting tumorigenesis.

More Related Videos

Real-Time Monitoring of Aurora kinase A Activation using Conformational FRET Biosensors in Live Cells06:29

Real-Time Monitoring of Aurora kinase A Activation using Conformational FRET Biosensors in Live Cells

Published on: July 30, 2020

The Soft Agar Colony Formation Assay08:01

The Soft Agar Colony Formation Assay

Published on: October 27, 2014

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
Covalently Linked Protein Regulators02:04

Covalently Linked Protein Regulators

Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein.